Drugmaker Takeda's CEO Weber to step down, raises profit forecast
Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's ...
Takeda picks first woman as CEO of centuries-old drugmaker
Julie Kim has been running Takeda’s US operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval.
The Business Journals2d
Takeda’s next CEO is a familiar face in Massachusetts biotech scene
On Thursday, Takeda Pharmaceutical Co. (NYSE:TAK) announced that its board of directors had selected Julie Kim, president of Takeda’s U.S. business unit, as Weber’s successor. The life ...
Takeda gains after FY24 guidance raise, CEO transition
Takeda (TAK) stock rose in premarket trading after raising its full-year outlook and appointing Julie Kim as the next CEO.